New Antibody Developed for Virus Affecting 95% of Humans
Scientists at the Fred Hutch Cancer Center have engineered first-of-its-kind genetically human monoclonal antibodies that block the Epstein-Barr virus (EBV). By targeting key surface antigens gp350 and gp42, the team ... Read More